GPC3 and hepatocellular carcinoma: JCO 41:TPS624-TPS624 Xie C, Mcm B, Mabry-Hrones D et al (2023) A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).